Very recently, carnitine deficiency due to mutations in the SLC22A5 gene encoding the ubiquitary membrane carnitine transporter OCTN2, have been associated to SQT, likely due to secondarily increased K+ channel activity (Roussel et al., 2016). The gene discussed is SLC22A5; the disease is systemic primary carnitine deficiency disease.